Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

NAR molecular medicine

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
NAR Molecular Medicine|December 13, 2024
<i>C9orf72</i> repeat expansion creates the unstable folate-sensitive fragile site FRA9AMila Mirceta, Monika H M Schmidt, Natalie Shum, et al.
NAR Molecular Medicine|December 22, 2025
Gamma-retrovirus design for efficacious microRNA-mediated gene knock-down and protein co-expression without compromising titersRomain Vuillefroy de Silly, Bili Seijo, Jimmy Maillard, et al.
NAR Molecular Medicine|January 15, 2026
The nuclear and mitochondrial genomes need to tango. How is their dance synchronized during development?Justin C St John
NAR Molecular Medicine|January 12, 2026
Transcript-Capture sequencing enriches mRNA of <i>Mycobacterium tuberculosis</i> from host samplesEleanor I Lamont, Richard M Jones, Jessica Assadi, et al.
NAR Molecular Medicine|November 21, 2025
Polypeptide encoded by the -1 PRF signal of SARS-CoV-2 controls multiple enzymatic activities of the viral NiRAN domainHsiu-Ting Hsu, Che-Pei Cho, Chia-Liang Lin, et al.
NAR Molecular Medicine|November 19, 2025
Tri-snRNP activity modulates tauopathy phenotypesKatherine R LeBlanc, Randall J Eck, Aleen D Saxton, et al.
NAR Molecular Medicine|November 19, 2025
JAK inhibitors remove innate immune barriers facilitating viral propagationErlend Ravlo, Aleksandr Ianevski, Marius Nårstad Skipperstøen, et al.
NAR Molecular Medicine|November 19, 2025
Targeted deletions in human mitochondrial DNA engineered by Type V CRISPR-Cas12a systemNatalia Nikitchina, Anne-Marie Heckel, Nikita Shebanov, et al.
NAR Molecular Medicine|November 19, 2025
Indole-containing inhibitors with improved efficacy targeting the gyrase of <i>Mycobacterium tuberculosis</i>Shankar Bhattarai, Vinay Shankar Tiwari, Benjamin Tam, et al.
NAR Molecular Medicine|November 19, 2025
FTLD-MAPT mutations and short 5'UTR Tau mRNAs increase Tau translationPaulo J da Costa, Antoine Perret, Luc Buée, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
NAR Molecular Medicine|December 13, 2024
<i>C9orf72</i> repeat expansion creates the unstable folate-sensitive fragile site FRA9AMila Mirceta, Monika H M Schmidt, Natalie Shum, et al.
NAR Molecular Medicine|December 22, 2025
Gamma-retrovirus design for efficacious microRNA-mediated gene knock-down and protein co-expression without compromising titersRomain Vuillefroy de Silly, Bili Seijo, Jimmy Maillard, et al.
NAR Molecular Medicine|January 15, 2026
The nuclear and mitochondrial genomes need to tango. How is their dance synchronized during development?Justin C St John
NAR Molecular Medicine|January 12, 2026
Transcript-Capture sequencing enriches mRNA of <i>Mycobacterium tuberculosis</i> from host samplesEleanor I Lamont, Richard M Jones, Jessica Assadi, et al.
NAR Molecular Medicine|November 21, 2025
Polypeptide encoded by the -1 PRF signal of SARS-CoV-2 controls multiple enzymatic activities of the viral NiRAN domainHsiu-Ting Hsu, Che-Pei Cho, Chia-Liang Lin, et al.
NAR Molecular Medicine|November 19, 2025
Tri-snRNP activity modulates tauopathy phenotypesKatherine R LeBlanc, Randall J Eck, Aleen D Saxton, et al.
NAR Molecular Medicine|November 19, 2025
JAK inhibitors remove innate immune barriers facilitating viral propagationErlend Ravlo, Aleksandr Ianevski, Marius Nårstad Skipperstøen, et al.
NAR Molecular Medicine|November 19, 2025
Targeted deletions in human mitochondrial DNA engineered by Type V CRISPR-Cas12a systemNatalia Nikitchina, Anne-Marie Heckel, Nikita Shebanov, et al.
NAR Molecular Medicine|November 19, 2025
Indole-containing inhibitors with improved efficacy targeting the gyrase of <i>Mycobacterium tuberculosis</i>Shankar Bhattarai, Vinay Shankar Tiwari, Benjamin Tam, et al.
NAR Molecular Medicine|November 19, 2025
FTLD-MAPT mutations and short 5'UTR Tau mRNAs increase Tau translationPaulo J da Costa, Antoine Perret, Luc Buée, et al.
Pageof 11